ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.

DYN Dyne Therapeutics Inc

24.73
1.04 (4.37%)
Apr 26 2024 - Closed
Delayed by 15 minutes

Period:

Draw Mode:

Volume 616,906
Bid Price 24.31
Ask Price 27.78
News -
Day High 25.12

Low
6.40

52 Week Range

High
30.2687

Day Low 23.50
Share Name Share Symbol Market Stock Type
Dyne Therapeutics Inc DYN NASDAQ Common Stock
  Price Change Price Change % Share Price Last Trade
1.04 4.37% 24.73 23:00:08
Open Price Low Price High Price Close Price Previous Close
23.79 23.50 25.12 24.73 23.695
Trades Shares Traded VWAP Financial Volume Average Volume 52 Week Range
8,748 616,906 US$ 24.79 US$ 15,290,322 - 6.40 - 30.2687
Last Trade Type Quantity Price Currency
15:20:01 formt 452 US$ 24.73 USD

Dyne Therapeutics Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
2.03B 81.96M - 0 -235.94M -2.88 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

Dyne Therapeutics News

Date Time Source News Article
3/27/202415:05GlobeNewswire Inc.Dyne Therapeutics Reports Inducement Grant Under Nasdaq..
3/27/202407:30GlobeNewswire Inc.Dyne Therapeutics to Present at the Cantor Virtual Muscular..
3/25/202406:30GlobeNewswire Inc.Dyne Therapeutics Announces CEO Transition
3/13/202406:30GlobeNewswire Inc.Dyne Therapeutics to Present at Stifel 2024 Virtual CNS Days
3/11/202416:36Edgar (US Regulatory)Form 144 - Report of proposed sale of securities
3/11/202416:35Edgar (US Regulatory)Form 144 - Report of proposed sale of securities
3/11/202416:35Edgar (US Regulatory)Form 144 - Report of proposed sale of securities
3/08/202415:53Edgar (US Regulatory)Form 144 - Report of proposed sale of securities
3/07/202419:19Edgar (US Regulatory)Form 144 - Report of proposed sale of securities
3/07/202419:18Edgar (US Regulatory)Form 144 - Report of proposed sale of securities
3/07/202419:16Edgar (US Regulatory)Form 144 - Report of proposed sale of securities
3/05/202407:22Edgar (US Regulatory)Form S-3ASR - Automatic shelf registration statement of..
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No DYN Message Board. Create One! See More Posts on DYN Message Board See More Message Board Posts

Historical DYN Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week23.5326.329923.1124.57822,3201.205.10%
1 Month28.3129.0023.1126.01890,608-3.58-12.65%
3 Months22.0930.268720.4025.901,309,2392.6411.95%
6 Months6.8430.26876.4019.721,515,10217.89261.55%
1 Year10.6130.26876.4017.501,001,54614.12133.08%
3 Years18.3830.26874.3015.93498,5146.3534.55%
5 Years23.4532.3154.3016.36474,2121.285.46%

Dyne Therapeutics Description

Dyne Therapeutics Inc is a bio-technology company focused on providing therapeutics for patients with genetically driven diseases. The company is developing therapies for muscle disorders like Myotonic dystrophy, Duchenne muscular dystrophy, and Facioscapulohumeral muscular dystrophy.

Your Recent History

Delayed Upgrade Clock